These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 20603835)
41. Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. Ehata S; Hanyu A; Hayashi M; Aburatani H; Kato Y; Fujime M; Saitoh M; Miyazawa K; Imamura T; Miyazono K Cancer Res; 2007 Oct; 67(20):9694-703. PubMed ID: 17942899 [TBL] [Abstract][Full Text] [Related]
42. Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes. Yoon JH; Jung SM; Park SH; Kato M; Yamashita T; Lee IK; Sudo K; Nakae S; Han JS; Kim OH; Oh BC; Sumida T; Kuroda M; Ju JH; Jung KC; Park SH; Kim DK; Mamura M EMBO Mol Med; 2013 Nov; 5(11):1720-39. PubMed ID: 24127404 [TBL] [Abstract][Full Text] [Related]
43. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling. Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129 [TBL] [Abstract][Full Text] [Related]
44. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283 [TBL] [Abstract][Full Text] [Related]
45. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II. Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924 [TBL] [Abstract][Full Text] [Related]
46. HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro. Zhao J; Wang L; Cao AL; Jiang MQ; Chen X; Wang Y; Wang YM; Wang H; Zhang XM; Peng W Cell Physiol Biochem; 2016; 38(5):1761-74. PubMed ID: 27161221 [TBL] [Abstract][Full Text] [Related]
47. Retinoic acid remodels extracellular matrix (ECM) of cultured human fetal palate mesenchymal cells (hFPMCs) through down-regulation of TGF-β/Smad signaling. Li X; Zhang L; Yin X; Gao Z; Zhang H; Liu X; Pan X; Li N; Yu Z Toxicol Lett; 2014 Mar; 225(2):208-15. PubMed ID: 24374174 [TBL] [Abstract][Full Text] [Related]
48. Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis. Kawamata S; Matsuzaki K; Murata M; Seki T; Matsuoka K; Iwao Y; Hibi T; Okazaki K Inflamm Bowel Dis; 2011 Mar; 17(3):683-95. PubMed ID: 20602465 [TBL] [Abstract][Full Text] [Related]
49. Smad signaling pathway is a pivotal component of tissue inhibitor of metalloproteinases-3 regulation by transforming growth factor beta in human chondrocytes. Qureshi HY; Ricci G; Zafarullah M Biochim Biophys Acta; 2008 Sep; 1783(9):1605-12. PubMed ID: 18471442 [TBL] [Abstract][Full Text] [Related]
50. CTGF mediates Smad-dependent transforming growth factor β signaling to regulate mesenchymal cell proliferation during palate development. Parada C; Li J; Iwata J; Suzuki A; Chai Y Mol Cell Biol; 2013 Sep; 33(17):3482-93. PubMed ID: 23816882 [TBL] [Abstract][Full Text] [Related]
51. Effects of all-trans retinoic acid on signal pathway of cyclooxygenase-2 and Smad3 in transforming growth factor-β-stimulated glomerular mesangial cells. Han J; Zhang L; Chen X; Yang B; Guo N; Fan Y Exp Biol Med (Maywood); 2014 Mar; 239(3):272-83. PubMed ID: 24500985 [TBL] [Abstract][Full Text] [Related]
52. Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells. Anumanthan G; Halder SK; Osada H; Takahashi T; Massion PP; Carbone DP; Datta PK Br J Cancer; 2005 Nov; 93(10):1157-67. PubMed ID: 16251876 [TBL] [Abstract][Full Text] [Related]
53. Receptor type protein tyrosine phosphatase-kappa mediates cross-talk between transforming growth factor-beta and epidermal growth factor receptor signaling pathways in human keratinocytes. Xu Y; Baker D; Quan T; Baldassare JJ; Voorhees JJ; Fisher GJ Mol Biol Cell; 2010 Jan; 21(1):29-35. PubMed ID: 19864455 [TBL] [Abstract][Full Text] [Related]
54. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells. Matsuo SE; Leoni SG; Colquhoun A; Kimura ET J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618 [TBL] [Abstract][Full Text] [Related]
55. Increased Expression of TGF-β Signaling Components in a Mouse Model of Fibrosis Induced by Submandibular Gland Duct Ligation. Woods LT; Camden JM; El-Sayed FG; Khalafalla MG; Petris MJ; Erb L; Weisman GA PLoS One; 2015; 10(5):e0123641. PubMed ID: 25955532 [TBL] [Abstract][Full Text] [Related]
56. Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-beta. Xie S; Sukkar MB; Issa R; Khorasani NM; Chung KF Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L245-53. PubMed ID: 17468136 [TBL] [Abstract][Full Text] [Related]
57. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2. Song K; Cornelius SC; Reiss M; Danielpour D J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289 [TBL] [Abstract][Full Text] [Related]
58. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors. Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428 [TBL] [Abstract][Full Text] [Related]
59. TGF-β1 as possible link between loss of bone mineral density and chronic inflammation. Ehnert S; Baur J; Schmitt A; Neumaier M; Lucke M; Dooley S; Vester H; Wildemann B; Stöckle U; Nussler AK PLoS One; 2010 Nov; 5(11):e14073. PubMed ID: 21124921 [TBL] [Abstract][Full Text] [Related]
60. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells. Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]